ReviewMedicine2017
Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review.
Review in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- PEComas: current concepts in diagnosis, molecular pathways, and emerging treatments.The oncologist · 2026Review
- Characteristics and Treatment of Primary Hepatic Perivascular Epithelioid Cell Tumor (PEComa) in Adults: A Systematic Review.Cancers · 2025Review
- Imaging features of CT and MR in hepatic perivascular epithelioid cell tumor: case series and literature review.Frontiers in oncology · 2025Article
- Hepatic perivascular epithelioid cell tumors: Benign, malignant, and uncertain malignant potential.World journal of gastroenterology · 2024Article
- Primary Liver Perivascular Epithelioid Cell Tumor (PEComa): Case Report and Literature Review.Medicina (Kaunas, Lithuania) · 2024Review
- Case report: Liver PEComa after kidney transplantation in recipient with tuberous sclerosis complex.Frontiers in oncology · 2024Article
- Insights into clinical diagnosis and treatment of malignant hepatic perivascular epithelioid cell tumor.Intractable & rare diseases research · 2022Article
- PEComa-A Rare Liver Tumor.Journal of clinical medicine · 2021Article
- Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation.Cancer imaging : the official publication of the International Cancer Imaging Society · 2019Article
- Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management.World journal of clinical oncology · 2019Review
- Computed tomography imaging features of hepatic perivascular epithelioid cell tumor: A case report and literature review.Medicine · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerivascular epithelioid cell tumors (PEComas) are extremely rare mesenchymal entities with potentially malignant properties; the liver cases are not encountered frequently. Owing to themalignant potential, these tumors are treated by surgical methods to ensure total resection. In the present report, a case of liver PEComa treated by embolization combined with radiofrequency ablation (RFA) has been described. CASE SUMMARY: A 40-year-old female was admitted for the detection of a liver mass during an annual physical examination. The patient did not have any liver disease background, enhanced computed tomography (CT), and magnetic resonance revealed a huge mass in the right lobe. Pathology gave the diagnosis of PEComa, for disagreement of open surgery, a combination of transarterial embolization (TAE) and RFA were applied for treatment and the outcomes were acceptable, the patient was under follow-up to observe the long-term effect.
conclusionInterventional procedures such as TAE and RFA are feasible and effective for such lesions and may serve as an alternate when resection is not indicated. Prospective studies are warranted to verify the long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.